• 1
    Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet 1956; 271: 11211125.
  • 2
    Shear L, Kleinerman J, Gabuzda GJ. Renal failure in patients with cirrhosis of liver. I. Clinical and pathologic characteristics. Am J Med 1965; 39: 184198.
  • 3
    Ginès P, Cárdenas A, Schrier RW. Liver disease and the kidney. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007: 21792205.
  • 4
    Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 13101318.
  • 5
    European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397417.
  • 6
    Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164176.
  • 7
    Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010; 52: 605613.
  • 8
    Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 702709.
  • 9
    Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, et al.; for ADQI Workgroup. Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2012; 16: R23.
  • 10
    Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, et al.; for TRIBE-AKI Consortium. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2013; 57: 753762.
  • 11
    Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut 2013; 62: 131137.
  • 12
    Piano S, Rosi S, Maresio G, Fasoilato S, Morando F, Romano A, et al. Comparison between conventional criterion and AKIN criteria in the definition of acute kidney injury in hospitalized patients with cirrhosis and ascites [abstract]. Hepatology 2012; 56: 126A.
  • 13
    Fagundes C, Guevara M, García-López E, Pereira GH, Solà E, Rodríguez E, et al. Acute Kidney Injury Network (AKIN) criteria for acute renal failure predicts outcome in hospitalized cirrhotic patients. A prospective study. J Hepatol 2011; 54: LB15.
  • 14
    Martin-Llahi M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140: 488496.
  • 15
    Cárdenas A, Ginès P. A patient with cirrhosis and increasing creatinine level: what is it and what to do? Clin Gastroenterol Hepatol 2009; 7: 12871291.
  • 16
    Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 2012; 57: 23622370.
  • 17
    Fagundes C, Pépin MN, Guevara M, Barreto R, Casals G, Solà E, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol 2012; 57: 267273.
  • 18
    Ginès P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome. Lancet 2003; 362: 18191827.
  • 19
    Fernández J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012; 56( suppl 1): S1S12.
  • 20
    Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 12821289.
  • 21
    Ruiz-del-Arbol L, Monescillo A, Jimenéz W, Garcia-Plaza A, Arroyo V, Rodés J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579586.
  • 22
    Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 14931502.
  • 23
    Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 2012; 55: 11721181.
  • 24
    Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001; 34: 671676.
  • 25
    Salerno F, Badalamenti S. Drug induced renal failure in cirrhosis. In: Ginès P, Arroyo V, Rodes J, Schrier R, eds. Ascites and Renal Dysfunction in Liver Disease. 2nd ed. Oxford, United Kingdom: Blackwell Publishing; 2005: 372382.